JP1702591S - - Google Patents

Info

Publication number
JP1702591S
JP1702591S JPD2021-7658F JP2021007658F JP1702591S JP 1702591 S JP1702591 S JP 1702591S JP 2021007658 F JP2021007658 F JP 2021007658F JP 1702591 S JP1702591 S JP 1702591S
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JPD2021-7658F
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JPD2021-7658F priority Critical patent/JP1702591S/ja
Priority to US29/807,848 priority patent/USD1034599S1/en
Application granted granted Critical
Publication of JP1702591S publication Critical patent/JP1702591S/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JPD2021-7658F 2021-04-12 2021-04-12 Active JP1702591S (enExample)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JPD2021-7658F JP1702591S (enExample) 2021-04-12 2021-04-12
US29/807,848 USD1034599S1 (en) 2021-04-12 2021-09-15 Stand with monitor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JPD2021-7658F JP1702591S (enExample) 2021-04-12 2021-04-12

Publications (1)

Publication Number Publication Date
JP1702591S true JP1702591S (enExample) 2021-12-20

Family

ID=79644911

Family Applications (1)

Application Number Title Priority Date Filing Date
JPD2021-7658F Active JP1702591S (enExample) 2021-04-12 2021-04-12

Country Status (2)

Country Link
US (1) USD1034599S1 (enExample)
JP (1) JP1702591S (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP1687276S (enExample) * 2020-08-12 2021-06-07
JP1687275S (enExample) * 2020-08-12 2021-06-07
USD1090861S1 (en) * 2024-01-15 2025-08-26 Lumaflex LLC Stand for a therapy device

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5687939A (en) * 1996-04-26 1997-11-18 Moscovitch; Jerry Dual display system
USD626235S1 (en) * 2009-04-24 2010-10-26 B-K Medical Aps Ultrasound scanner
WO2014058929A1 (en) * 2012-10-08 2014-04-17 Fujifilm Sonosite, Inc. Systems and methods for touch-based input on ultrasound devices
USD712540S1 (en) * 2013-10-08 2014-09-02 Fujifilm Sonosite, Inc. Ultrasound device
USD732496S1 (en) * 2013-10-22 2015-06-23 Cisco Technology, Inc. Video conference system endpoint display and stand
USD739538S1 (en) * 2014-09-17 2015-09-22 Lawrence Bernal Medical computer cart
USD771817S1 (en) * 2015-03-06 2016-11-15 Align Technology, Inc. Combined cart-mounted display and computer for intraoral scanner
JP1542687S (enExample) * 2015-08-26 2016-02-01
USD852961S1 (en) * 2015-12-09 2019-07-02 Energize Medical Llc Medical console with display
USD796679S1 (en) * 2016-06-14 2017-09-05 Fujifilm Sonosite, Inc. Portable ultrasound device
USD879303S1 (en) * 2016-12-23 2020-03-24 Aesculap Ag Combined surgical navigation system monitor and stand
USD911529S1 (en) * 2018-06-14 2021-02-23 General Electric Company Combined monitor and cart
USD967093S1 (en) * 2019-12-17 2022-10-18 Lg Electronics Inc. Electronic canvas

Also Published As

Publication number Publication date
USD1034599S1 (en) 2024-07-09

Similar Documents

Publication Publication Date Title
JP1702591S (enExample)
BR102021007058A2 (enExample)
BR102020022030A2 (enExample)
AR134288A1 (es) UN PÉPTIDO CÍCLICO PARA ATRAPAR LA INTERLEUCINA-1b
AR134282A1 (es) Compuestos y composiciones farmacéuticas que degradan el regulador de la subfamilia a de la cromatina dependiente de actina asociado a la matriz relacionado con swi / snf
AR134276A1 (es) ANTICUERPOS ANTI-MIGIS-a Y MÉTODOS DE USO DE ESTOS
AR134275A1 (es) Anticuerpos cd24
AR134271A1 (es) Variantes de cnp, conjugados y formulaciones de los mismos
AR134266A1 (es) Métodos para tratar el cáncer utilizando compuestos que inhiben la pkmyt1
AR134264A1 (es) Correctores farmacológicos de rodopsina y sus usos
AR134263A1 (es) Tratamiento de covid persistente con composición de vesículas extracelulares
AR134262A1 (es) Formulación líquida de agente biológico en almacenamiento estable
AR134259A1 (es) Compuestos de pirimidina bicíclicos, métodos y usos de estos
AR134258A1 (es) Degradadores bcl-xl heterobifuncionales de tetrahidroisoquinolina
AR134257A1 (es) Degradadores bcl-xl heterobifuncionales de tetrahidroisoquinolina
AR134219A1 (es) Derivados de (piperidin-4-il)-1,5-naftiridina y (piperidin-4-il)quinolina sustituidos y usos de los mismos
AR134215A1 (es) Compuestos de tiazol y métodos de uso
AR134214A1 (es) Redireccionamiento de cápsides de aav para dirigirlas al sistema nervioso central
AR134203A1 (es) Compuestos para la degradación de braf mutante
AR134200A1 (es) Combinaciones de herbicida / protector a base de herbicidas de la clase de las amidas de ácido n-(1,3,4-oxadiazol-2-il)fenilcarboxílico quirales y sus sales
AR134198A1 (es) Compuestos de proteasa 1 de procesamiento específico de ubiquitina (usp1)
AR134193A1 (es) Métodos para tratar tumores tenosinoviales de células gigantes
AR134194A1 (es) Nuevos moduladores de nitrato, amonio y potasio en plantas y métodos para usarlos
AR134185A1 (es) Anticuerpos anti-receptor de transferrina y usos de estos
AR134180A1 (es) Péptidos inmunogénicos de magea1, proteínas de unión que reconocen los péptidos inmunogénicos de magea1 y usos de los mismos